HOUSLEY ANDRECE (Chief Financial Officer) received a stock award from INSYS THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 6/6/2019ACC: 0001209191-19-035145
Officer· Chief Financial Officer
Since Apr 2019
+35K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
35K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+3.99K
Price / share
—
Trade value
—
% of position
23.5%
4/17/2019
17K→20.99K
Total
Net shares
+3.99K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/17/2019 | A · Award | +3.99K | — | — | 23.5% | 17K | 20.99K |
| Total | +3.99K | $0.00 | ||||||
Derivative Transactions1
Employee Stock Option (right to buy)
Direct
Converts to
Common Stock
31.01K shares
Shares
+31.01K
Strike price
4.30
Held after
31.01K
Exercisable
—
4/17/2019
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) Direct | Common Stock31.01K shares | 4/17/2019 | A · Award | +31.01K | 4.30 | — | 31.01K |